Borzym-Kluczyk Małgorzata, Radziejewska Iwona, Cechowska-Pasko Marzanna, Darewicz Barbara
Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Białystok, Poland.
Department of Medical Chemistry, Medical University of Bialystok, Białystok, Poland.
Acta Biochim Pol. 2017;64(3):465-470. doi: 10.18388/abp.2015_1215. Epub 2017 Jul 24.
Cancer cells are characterized by an aberrant increase in protein N-glycosylation and by disruption of E-cadherin-mediated adherens junctions. However, the relationship between alterations in N-glycosylation process and loss of E-cadherin adhesion in cancer remains unclear. The mechanisms of altered expression of adhesive glycoproteins in cancer cells have not been fully elucidated. Thus, the aim of this study was to examine the expression of E-cadherin and sialyl Lewis/, NeuAcα2-3Gal, NeuAcα2-6Gal/GalNAc structures in the normal renal tissue and intermediate and cancerous tissues from patients with clear cell RCC. Moreover, we attempted to correlate the E-cadherin expression with some specific sugar residues of renal cancer tissue glycoproteins. The expression of E-cadherin was analysed using ELISA test and immunoblotting. Oligosaccharide structures and sialylation level were detected with ELISA test using specific biotinylated lectins or antibodies. A significant decrease of E-cadherin expression as well as a significant increase in sialylated oligosaccharides level in intermediate zone and renal cancer tissue in comparison to normal renal tissue are reported. Significant decrease in expression of cadherins and increase in sialylation of oligosaccharide structures in renal cancer tissue in comparison to normal renal tissue, and in renal cancer tissue in comparison to intermediate zone of renal tissue, are important for the future research concerning detection and quantification of cadherins and sialylated oligosaccharide structures in urine and cells of urinary sediment as possible non-invasive marker of early RCC.
癌细胞的特征在于蛋白质N-糖基化异常增加以及E-钙黏蛋白介导的黏附连接的破坏。然而,癌症中N-糖基化过程改变与E-钙黏蛋白黏附丧失之间的关系仍不清楚。癌细胞中黏附糖蛋白表达改变的机制尚未完全阐明。因此,本研究的目的是检测透明细胞肾细胞癌患者正常肾组织、中间组织和癌组织中E-钙黏蛋白以及唾液酸化路易斯抗原、NeuAcα2-3Gal、NeuAcα2-6Gal/GalNAc结构的表达。此外,我们试图将E-钙黏蛋白的表达与肾癌组织糖蛋白的一些特定糖残基相关联。使用ELISA试验和免疫印迹分析E-钙黏蛋白的表达。使用特异性生物素化凝集素或抗体通过ELISA试验检测寡糖结构和唾液酸化水平。据报道,与正常肾组织相比,中间区和肾癌组织中E-钙黏蛋白表达显著降低,唾液酸化寡糖水平显著升高。与正常肾组织相比,以及与肾组织中间区相比,肾癌组织中钙黏蛋白表达显著降低,寡糖结构唾液酸化增加,这对于未来关于检测和定量尿液及尿沉渣细胞中钙黏蛋白和唾液酸化寡糖结构作为早期肾细胞癌可能的非侵入性标志物的研究具有重要意义。